Tamoxifen Citrate

Thông số

54965-24-1Số CAS

259-415-2Số EC

2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acidTên IUPAC

C32H37NO8Công thức hóa học

563.6 g/molKhối lượng phân tử

Tamoxifen citrate; 54965-24-1; Zitazonium; Kessar; Zemide; Jenoxifen; Ledertam; Nourytam; Noxitem; Oncotam; Tamofen; Tamofene; Tomaxasta; Zynoplex; Emblon; Nolgen; Noltam; Tamax; ICI 46,474; DTXSID8021301; Tamoxifeni citras; NSC-180973; NSC-757345; 7FRV7310N6; I.C.I.46474 CITRATE; NSC180973; DTXCID101301; (Z)-2-(p-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine citrate (1:1); trans-1-(p-beta-Dimethylaminoethoxyphenyl)-1,2-diphenylbut-1-ene citrate; Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Ethanamine, 2-(4-((1Z)-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Clonoxifen; Dignotamoxi; Estroxyn; Fentamox; Kentadex; Lesporene; Novofen; Oestrifen; Tamaxin; Tamifen; Ebefen; Nolvadex fte; Novo-Tamoxifen; Gen-Tamoxifen; Nolvadex d; Pms-Tamoxifen; Nolvadex-D; (Z)-2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine citrate; (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine citrate; Oestrifen-10; Oestrifen-20; Oestrifen-40; Citrate, Tamoxifen; Fentamox 10; Fentamox 20; Kessar 10; Kessar 20; RefChem:891063; 1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene Citrate; (Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate; CHEBI:9397; Istubal; Soltamox; Tamoxifen (Citrate); Tamoxifen citrate salt; MFCD00058321; ICI 46474; ICI-46474; Tamoxifen Citrate (Nolvadex); s1238; NCGC00024928-06; CAS-54965-24-1; Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Farmifeno; Ginarsan; Nourytan; Tafoxen; Tamoxasta; Terimon; Genox; Tamoxifencitrate; Tamox-Puren; 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid; SMR000677949; Z-Tamoxifen citrate; SR-01000075523; UNII-7FRV7310N6; CCRIS 6718; 54965-24-1 (citrate); Tamoxifen Citrate?; Nolvadex (TN); Soltamox (TN); 2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt); Prestwick_458; EINECS 259-415-2; Tamoxifen citrate [USAN:USP:JAN]; Tamoxifen citrate RS; Tamoxifen citrate CRS; Lopac-T-9262; CHEMBL786; SCHEMBL6365; MLS001055370; MLS002154210; SPECTRUM1500557; Nolvadex (TN) (AstraZeneca); TAMOXIFEN CITRATE [MI]; orb1224703; orb1310249; orb3025056; TAMOXIFEN CITRATE [JAN]; Tamoxifen (Citrate) (Standard); Tamoxifen citrate (JP18/USP); TAMOXIFEN CITRATE [USAN]; HMS500M20; Tamoxifen citrate salt, >=99%; TAMOXIFEN CITRATE [VANDF]; TAMOXIFEN CITRATE [MART.]; GLXC-26314; HMS1568M14; HMS1921C13; HMS2092K17; HMS2095M14; HMS2232E08; HMS3263B08; HMS3675P04; HMS3712M14; HMS5079C21; HMS5080B11; Pharmakon1600-01500557; TAMOXIFEN CITRATE [USP-RS]; TAMOXIFEN CITRATE [WHO-DD]; TAMOXIFEN CITRATE [WHO-IP]; EX-A5777; Tox21_110938; Tox21_202070; Tox21_300274; Tox21_501203; CCG-39629; EBC-11168; HY-13757R; NSC757345; s1972; SBB080554; AKOS005111126; Tox21_110938_1; CS-1852; FT32122; KS-5046; LP01203; TAMOXIFEN CITRATE [ORANGE BOOK]; TAMOXIFEN CITRATE [EP MONOGRAPH]; NCGC00016206-01; NCGC00016206-02; NCGC00016206-03; NCGC00016206-04; NCGC00016206-05; NCGC00016206-06; NCGC00024928-02; NCGC00024928-23; NCGC00094450-01; NCGC00094450-02; NCGC00094450-03; NCGC00094450-04; NCGC00254000-01; NCGC00259619-01; NCGC00261888-01; TAMOXIFEN CITRATE [USP MONOGRAPH]; TAMOXIFENI CITRAS [WHO-IP LATIN]; HY-13757; Tamoxifen citrate for performance test CRS; EU-0101203; NS00076420; SW219368-1; D00966; T 9262; SR-01000075523-1; SR-01000075523-3; SR-01000075523-5; SR-01000075523-6; Q27108378; SR-01000075523-10; (Z)-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene Citrate; Tamoxifen citrate, European Pharmacopoeia (EP) Reference Standard; (2)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine citrate; Tamoxifen citrate, United States Pharmacopeia (USP) Reference Standard; (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-ethanamine cirtrate (1:1); citric acid;2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine; Tamoxifen citrate for performance test, European Pharmacopoeia (EP) Reference Standard; (Z)-(2-(4-(1,2-Diphenylbut-1-enyl)phenoxy)ethyl)dimethylammonium dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate; {2-[4-((1Z)-1,2-diphenylbut-1-enyl)phenoxy]ethyl}dimethylamine, 2-hydroxypropa ne-1,2,3-tricarboxylic acid; {2-[4-(1,2-Diphenyl-1-buten-1-yl)phenoxy]ethyl}dimethylamine 2-hydroxy-1,2,3-propanetricarboxylate (; {2-[4-(1,2-Diphenyl-1-buten-1-yl)phenoxy]ethyl}dimethylamine 2-hydroxy-1,2,3-propanetricarboxylate salt; 2-Hydroxypropane-1,2,3-tricarboxylic acid--2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethan-1-amine (1/1); Ethanamine,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)Tên gọi khác